. . "Ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky hl\u00E1\u0161en\u00E9 \u2265 1% u pacient\u016F l\u00E9\u010Den\u00FDch loperamid-simetikonem (N= 618) uv\u00E1d\u00ED tabulka 1.\nTabulka 1. Ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky hl\u00E1\u0161en\u00E9 \u2265 1% u pacient\u016F l\u00E9\u010Den\u00FDch loperamid-simetikonem\n v\u00A0p\u011Bti kontrolovan\u00FDch klinick\u00FDch studi\u00EDch s\u00A0loperamid-simetikonem\n\tT\u0159\u00EDda org\u00E1nov\u00FDch syst\u00E9m\u016F \n\tloperamid-simetikon\n\tloperamid\n\tsimetikon\n\tplacebo\n\t\nNe\u017E\u00E1douc\u00ED \u00FA\u010Dinek\n\t\n% (N=618)\n\t\n% (N=449)\n\t\n% (N=446)\n\t\n%(N=527)\n\t\nGastrointestin\u00E1ln\u00ED poruchy\n\t\n\t\n\t\n\t\n\tNauzea\n\t1,6\n\t1,1\n\t0,4\n\t0,4\n\t\nPoruchy nervov\u00E9ho syst\u00E9mu\n\t\n\t\n\t\n\t\n\tPorucha chuti\n\t2,6\n\t3,8*\n\t2,5\n\t1,1\nPozn\u00E1mka: \u010Cty\u0159i studie porovn\u00E1valy loperamid-simetikon s\u00A0loperamidem, simetikonem \uFFFDa placebem."@cs . . . "7628"^^ . . . . "8272"^^ . . . "2"^^ . .